Market Overview

UPDATE: JP Morgan Raises PT to $62 on Health Care REIT Post Q2

Related HCN
High-Yielding Health Care REIT Ventas Has Upward Guidance Helped By Acquisition
Markets Gather Some Momentum As Volume Remains Light, Geopolitical Tension Improving

JP Morgan reiterated its Overweight rating on Health Care REIT (NYSE: HCN) and increased its price target from $61 to $62.

JP Morgan commented, "Our OW rating on HCN is based on a number of factors including our belief that the stock has above-average growth prospects relative to the health care sector, and we see valuation attractive based on discounted trading multiples and an above-average dividend yield."

Health Care REIT closed at $60.17 on Thursday.

Posted-In: JP MorganAnalyst Color Price Target Reiteration Intraday Update Analyst Ratings

 

Related Articles (HCN)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters